SCYNEXIS Stock

SCYNEXIS Pre-Tax Margin

The Pre-Tax Profit Margin of SCYNEXIS (SCYX) as of Aug 8, 2026 is -564.26 %. In the previous year, Pre-Tax Profit Margin was 47.94 % — a change of -1,277.08% (lower).

Pre-Tax Margin

-564.26 %

YoY

-1,277.08%

Last updated:

Pre-Tax Profit Margin of SCYNEXIS is 2026 -564.26 % . Pre-Tax Profit Margin of SCYNEXIS was 2025 47.94 % . It decreases by -1,277.08% lower compared to the previous year.
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Pre-Tax Profit Margin of SCYNEXIS is -564.26 % in 2026.

Pre-Tax Profit Margin of SCYNEXIS changed from 47.94 % to -564.26 %, representing a -1,277.08% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's SCYNEXIS with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

Margins — SCYNEXIS

All Key Metrics — SCYNEXIS